Sound Income Strategies »

Ovid Therapeutics shares owned by Sound Income Strategies

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Sound Income Strategies from 13F filings

Historical chart of Sound Income Strategies investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Sound Income Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Sound Income Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $18 6 3.00

More positions owned by Sound Income Strategies

Hercules Technology Growth Capital (HTGC)
Sixth Street Specialty Lending (TSLX)
Golub Capital BDC (GBDC)
Ares Capital Corporation (ARCC)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Owl Rock Capital Corporation (OBDC)
Pennantpark Floating Rate Capi (PFLT)
Vaneck Vectors Etf Tr Emerging Mkts Hi (HYEM)
Ishares Jp Mrgn Em Hi Bd (EMHY)
First Tr Exchng Traded Fd Vi Tcw Emerging Mkt (EFIX)
Tidal Etf Tr Sound Enhanced (FXED)
Tidal Etf Tr Sound Equity Inm (DIVY)
Lyondellbasell Industries N Shs - A - (LYB)
Omni (OMC)
International Business Machines (IBM)

View all positions for Sound Income Strategies

Top funds holding Ovid Therapeutics

BVF
EcoR1 Capital
Madison Avenue Partners
Vanguard Group
Artal Group
Jpmorgan Chase & Co
TLS Advisors
Blue Owl Capital Holdings
Wells Fargo & Company
Fft Wealth Management
Dimensional Fund Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Assenagon Asset Management
Barclays

View all funds holding Ovid Therapeutics